{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&uin=HL2255", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptId=17&uin=HL2255", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&uin=HL2255&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answeringDeptId=17&uin=HL2255", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&uin=HL2255", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&uin=HL2255", "items" : [{"_about" : "http://data.parliament.uk/resources/1688056", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1688056/answer", "answerText" : {"_value" : "
The Government is engaging the market on its requirements for products that would enable Respiratory Syncytial Virus (RSV) programmes to be implemented for infants and older adults, following advice from the Joint Committee on Vaccination and Immunisation in 2023. A final decision on these programmes will be taken following the outcome of this process. If any RSV programmes are agreed to, their implementation will be announced to the public and health professionals in due course.<\/p>
Whilst population wide immunisation is not currently available, the Government is increasing efforts to minimise the number of severe cases of RSV. This is currently done by a targeted immunisation offer to those known to be at highest risk of severe complications. The National Health Service has also published signs and symptoms of RSV, and advice on when parents should bring their children to seek medical attention. The UK Health Security Agency has also provided public health messaging on social, national, and regional media, highlighting the signs and symptoms of RSV and the steps that can be taken to reduce infections, including reducing risks to young children.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2024-02-14", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-02-14T17:47:11Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-02-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Respiratory Syncytial Virus: Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government when they intend to outline a timeline for the implementation of Respiratory Syncytial Virus vaccination programmes for infants and older adults; and what plans they have to increase public awareness of the virus.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4130", "label" : {"_value" : "Biography information for Baroness Ritchie of Downpatrick"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Ritchie of Downpatrick"} ], "uin" : "HL2255"} , {"_about" : "http://data.parliament.uk/resources/1505689", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1505689/answer", "answerText" : {"_value" : "
There has been no change to the offer of COVID-19 vaccinations for children aged five to 11 years old. In February 2022, the Government accepted advice from the independent Joint Committee on Vaccination and Immunisation (JCVI) for a one-off, non-urgent vaccine offer for children aged five to 11 years old not in clinical risk groups. This offer has been applicable to children aged five years old by 31 August 2022 and eligible children may still receive this vaccination.<\/p>
On 15 July 2022, the Government accepted the advice of the JCVI to offer a booster vaccination in autumn 2022 for those at higher risk of severe COVID-19. All children aged five years old and over in a clinical risk group are eligible for a booster dose in the autumn campaign.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4582", "label" : {"_value" : "Biography information for Baroness Bloomfield of Hinton Waldrist"} } , "answeringMemberPrinted" : {"_value" : "Baroness Bloomfield of Hinton Waldrist"} , "dateOfAnswer" : {"_value" : "2022-09-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-09-26T11:23:51.457Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-09-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government why they have removed Covid vaccine access for five to 11 year olds given that recent rates of reported cases in children have exceeded those in adults.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/407", "label" : {"_value" : "Biography information for Baroness Taylor of Bolton"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Taylor of Bolton"} ], "uin" : "HL2255"} , {"_about" : "http://data.parliament.uk/resources/600502", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/600502/answer", "answerText" : {"_value" : "
As part of the New Care Models Programme, NHS England is supporting local health and care commissioners and providers to come together to improve the health and care they provide. This includes the development of population-based care models known as integrated Primary and Acute Care Systems and Multispecialty Community Providers (MCPs). Where and how to develop new care models are decisions taken by local partnerships, in response to local conditions. The Programme is not directing or requiring the amalgamation of primary care centres.<\/p>
<\/p>
There are 14 MCP vanguards, with a single organisation accountable for joined-up General Practitioner (GP) and community services and some specialist care, mental health services, and social care for a defined population. The building blocks of a MCP are the \u2018care hubs\u2019 of integrated teams. Each typically serves a community of around 30,000-50,000 people. These hubs are the practical, operational level of any model of accountable care provision. The wider the scope of services included in the MCP, the more hubs you may need to connect together to create sufficient scale. All 14 MCP vanguards now serve a minimum population of around 100,000.<\/p>
<\/p>
The majority of GP practices are already working in practice groups or federations. This provides opportunities to expand services, stabilise practice income and work at scale, which has benefits for patients, practices and the wider system. These include economies of scale, quality improvement, workforce development, enhanced care and new services, resilience and system partnerships.<\/p>
<\/p>
A new voluntary MCP contract will be introduced from April 2017, to integrate general practice services with community services and wider healthcare services. Measures from the GP Access Fund and vanguard sites that are currently piloting this approach, will be learned from to support mainstreaming of proven service improvements across all practices, and funding will be provided for local collaborations to support practices to implement new ways of working.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"} } , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"} , "dateOfAnswer" : {"_value" : "2016-10-26", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "HL2256"} , {"_value" : "HL2304"} , {"_value" : "HL2305"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-10-26T15:17:54.74Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-10-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Primary Health Care"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government whether they plan to amalgamate primary care centres into larger units covering approximately 30,000 patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/121", "label" : {"_value" : "Biography information for Lord Mawhinney"} } , "tablingMemberPrinted" : [{"_value" : "Lord Mawhinney"} ], "uin" : "HL2255"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 3, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }